Você procurou por: dialysis treatment (Inglês - Maltês)

dialysis
dijalisi

renal dialysis
dialiżi renali

electro-dialysis
eletrodialiżi

dialysis prescriptions may
f’ pazjenti b’ insuffiċjenza renali kronika, korrezzjoni għall- anemija tista ’ twassal għal żieda fl- aptit, u t- teħidtal- potassju u l- proteini.

- are under dialysis
- ikollok id- dijalisi

renal dialysis equipment
tagħmir ta dijalisi renali

peritoneal dialysis patients*
pazjenti li jagħmlu dijalisi tal- peritonew

subjects with renal failure necessitating dialysis treatment were not investigated.
l - informazzjoni kienet limitata f’ suġġetti b’ indeboliment renali moderat u sever. ma ġewx investigati suġġetti b’ insuffiċjenza renali li jkollhom bżonn kura bid- dijaliżi.

adult patients on peritoneal dialysis the treatment is divided into two stages:
pazjenti adulti fuq dijalisi peritonjali it- trattament huwa maqsum f’ żewġ stadji:

renal impairment requiring dialysis.
indeboliment tal-kliewi li jeħtieġ dijaliżi.

patients undergoing haemodialysis will require a supplementary dose of cefuroxime at the end of each dialysis treatment.
pazjenti li jkunu fuq l- emodijalisi ser ikunu jeħtieġu doża supplimentari ta ’ cefuroxime fit - tmiem ta ’ sessjoni ta ’ dijalisi.

dialysis dependent patients (off-dialysis)
pazjenti dipendenti fuq dijalisi (barra d-dijalisi)

twenty of the 24 patients who required dialysis at baseline were able to discontinue dialysis during soliris treatment.
għoxrin mill-24 pazjent li kienu jeħtieġu dijalisi fil-linja bażi kienu kapaċi li jwaqqfu d-dijalisi matul it-trattament b’soliris.

it is particularly important that your doctor knows if you have kidney disease and whether you undergo dialysis treatment.
huwa importanti b’mod partikolari li t-tabib tiegħek ikun jaf jekk inti għandekx mard tal-kliewi u jekk intix qed tieħu kura bid-dijaliżi.

for patients with renal dysfunction requiring dialysis an additional 200 mg dose of nevirapine following each dialysis treatment is recommended.
huwa rakkomandat li għal pazjenti li għandhom problemi fil-kliewi li jinħtieġu d-dijaliżi, 200 mg addizzjonali ta’ nevirapine huma meħtieġa wara kull trattament ta’ dijaliżi.

renal impairment for patients with renal dysfunction requiring dialysis an additional 200 mg dose of viramune following each dialysis treatment is recommended.
indeboliment fil- kliewi huwa rakkomandat li għal pazjenti li għandhom problemi fil- kliewi li jinħtieġu d- dijaliżi, 200 mg addizzjonali ta ’ viramune huma meħtieġa wara kull trattament ta ’ dijaliżi.

due to either your kidney condition or your dialysis treatment you may: develop a low or high level of calcium in your blood.
minħabba il-kondizzjoni tal-kliewi tiegħek jew il-kura ta’ dijalisi int għandek: mnejn tiżviluppa livell baxx jew għoli ta’ kalċju f’demmek.

treatment may be administered without regard to the timing of dialysis.
il-kura tista’ tingħata mingħajr ma jitqies il-ħin tad- dijalisi.

due to either your kidney condition or your dialysis treatment you may: • develop a low or high level of calcium in your blood.
minħabba il- kondizzjoni tal- kliewi tiegħek jew il- kura ta ’ dijaliżi int għandek: • mnejn tiżviluppa livell baxx jew għoli ta ’ kalċju f’ demmek.

the results suggest that supplementing nevirapine therapy with an additional 200 mg dose of nevirapine following each dialysis treatment would help offset the effects of dialysis on nevirapine clearance.
dawn ir-riżultati juru li għandha tiġi miżjuda t-terapija b’nevirapine permezz ta’ doża addizzjonali ta’ 200 mg nevirapine wara kull kura ta' dijaliżi, biex jagħmel tajjeb